HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prevalence of granular corneal dystrophy type 2-related TGFBI p.R124H variant in a South Korean population.

AbstractPurpose:
Granular corneal dystrophy type 2 (GCD2) is an autosomal dominant disorder and is associated with the arginine to histidine substitution at codon 124 (p.R124H) of the TGFBI gene. Although TGFBI p.R124H is known to be the most common corneal dystrophy-related pathogenic variant, there are few data on the frequency of this variant in the South Korean population.
Methods:
In total, 2,060 anonymous DNA samples from a public umbilical cord blood bank were tested for the TFGBI p.R124H variant using real-time PCR.
Results:
Six of the 2,060 samples [0.29%; 95% confidence interval (CI), 0.12-0.67%] were heterozygous for the TGFBI p.R124H variant. The prevalence of the GCD2-related TGFBI p.R124H variant in this population was estimated to be 291.3 per 100,000 [95% confidence interval (CI), 118.5-667.0].
Conclusions:
To our knowledge, this is the largest study that has estimated the prevalence of the GCD2-related TGFBI p.R124H variant in South Korea.
AuthorsJong Eun Park, Sun Ae Yun, Eun Youn Roh, Jong Hyun Yoon, Sue Shin, Chang-Seok Ki
JournalMolecular vision (Mol Vis) Vol. 27 Pg. 283-287 ( 2021) ISSN: 1090-0535 [Electronic] United States
PMID34012230 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2021 Molecular Vision.
Chemical References
  • Extracellular Matrix Proteins
  • Transforming Growth Factor beta
  • betaIG-H3 protein
Topics
  • Asian People
  • Corneal Dystrophies, Hereditary (epidemiology, genetics)
  • Extracellular Matrix Proteins (blood, genetics)
  • Fetal Blood
  • Humans
  • Mutation
  • Prevalence
  • Real-Time Polymerase Chain Reaction
  • Republic of Korea (epidemiology)
  • Transforming Growth Factor beta (blood, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: